We are live on ! Find out more
GC

Guggenheim Capital Portfolio holdings

AUM $12.9B
1-Year Est. Return 27.3%
This Fund
S&P 500
This Quarter Est. Return
+3.69%
1 Year Est. Return
+27.3%
3 Year Est. Return
+83.37%
5 Year Est. Return
+104.66%
10 Year Est. Return
+386.48%
AUM
$14.1B
AUM Growth
-$90M
Cap. Flow
-$394M
Cap. Flow %
-2.79%
Top 10 Hldgs %
21.48%
Holding
1,980
New
111
Increased
767
Reduced
962
Closed
123

Top Buys

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$17.3M
2
AAPL icon
Apple
AAPL
+$12.5M
3
LVS icon
Las Vegas Sands
LVS
+$10.1M
4
XOM icon
ExxonMobil
XOM
+$9.07M
5
ADP icon
Automatic Data Processing
ADP
+$7.98M

Sector Composition

Rank Sector Weight
1 Technology 28.17%
2 Healthcare 8.93%
3 Consumer Discretionary 8.08%
4 Financials 7.53%
5 Communication Services 7.04%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SLVM icon
1476
Sylvamo
SLVM
$1.5B
$453K ﹤0.01%
+6,597
New +$435K
EVBG
1477
DELISTED
Everbridge, Inc. Common Stock
EVBG
$451K ﹤0.01%
12,886
+4,408
+52% +$153K
PPBI
1478
DELISTED
Pacific Premier Bancorp
PPBI
$451K ﹤0.01%
19,617
+142
+0.7% +$3.15K
JRI icon
1479
Nuveen Real Asset Income & Growth Fund
JRI
$347M
$448K ﹤0.01%
36,810
+258
+0.7% +$2.99K
FCNCA icon
1480
First Citizens BancShares
FCNCA
$25.5B
$448K ﹤0.01%
266
-636
-71% -$1.06M
WRB icon
1481
W.R. Berkley
WRB
$26.8B
$446K ﹤0.01%
8,508
-11,691
-58% -$626K
HLX icon
1482
Helix Energy Solutions
HLX
$1.45B
$445K ﹤0.01%
37,297
-12,430
-25% -$139K
CSWC icon
1483
Capital Southwest
CSWC
$1.58B
$445K ﹤0.01%
17,063
+1,098
+7% +$28.2K
LGND icon
1484
Ligand Pharmaceuticals
LGND
$6.02B
$445K ﹤0.01%
5,283
-1,486
-22% -$118K
ATI icon
1485
ATI
ATI
$30.5B
$445K ﹤0.01%
8,026
-1,608
-17% -$90.1K
CVLT icon
1486
Commault Systems
CVLT
$5.53B
$444K ﹤0.01%
+3,650
New +$392K
VZIO
1487
DELISTED
VIZIO Holding Corp.
VZIO
$443K ﹤0.01%
41,018
+223
+0.5% +$2.38K
OCSL icon
1488
Oaktree Specialty Lending
OCSL
$1.12B
$441K ﹤0.01%
23,451
+1,151
+5% +$22.3K
LOPE icon
1489
Grand Canyon Education
LOPE
$3.88B
$441K ﹤0.01%
3,149
-12,619
-80% -$1.74M
XENE icon
1490
Xenon Pharmaceuticals
XENE
$6.24B
$440K ﹤0.01%
11,290
-98
-0.9% -$3.92K
TNDM icon
1491
Tandem Diabetes Care
TNDM
$1.29B
$439K ﹤0.01%
10,900
+1,576
+17% +$65.7K
HSIC icon
1492
Henry Schein
HSIC
$9.83B
$438K ﹤0.01%
6,827
-3,126
-31% -$220K
GPRE icon
1493
Green Plains
GPRE
$1.06B
$438K ﹤0.01%
27,590
+3,487
+14% +$67.2K
ALRM icon
1494
Alarm.com
ALRM
$2.78B
$436K ﹤0.01%
6,861
-1,480
-18% -$97.8K
RY icon
1495
Royal Bank of Canada
RY
$294B
$436K ﹤0.01%
4,096
-13,116
-76% -$1.35M
CRS icon
1496
Carpenter Technology
CRS
$27.7B
$434K ﹤0.01%
+3,964
New +$381K
VLY icon
1497
Valley National Bancorp
VLY
$8B
$433K ﹤0.01%
61,976
-4,626
-7% -$33.8K
ASB icon
1498
Associated Banc-Corp
ASB
$5.88B
$432K ﹤0.01%
20,404
-698
-3% -$14.7K
LGI
1499
Lazard Global Total Return & Income Fund
LGI
$238M
$430K ﹤0.01%
25,789
+3,499
+16% +$56.5K
SMPL icon
1500
Simply Good Foods
SMPL
$988M
$429K ﹤0.01%
11,879
-7,714
-39% -$276K

Similar funds

Guggenheim Capital's Q2 2024 Portfolio in Review

As of Q2 2024, Guggenheim Capital held 1,980 positions worth $14.1B, down 0.63% from $14.2B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Guggenheim Capital's Q2 2024 filing shows 111 new, 767 increased, 962 reduced and 123 closed positions. Its largest new stake was Arm: 48,961 shares worth $8.01M. The largest sale was VanEck Gold Miners ETF, an estimated $46.2M.

By sector, the portfolio is most concentrated in Technology at 28% of assets, up from 25% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Guggenheim Capital's largest Q2 2024 buy was Arm: 48,961 shares worth $8.01M.
  • Guggenheim Capital added most to Microsoft in Q2 2024, an estimated $17.3M increase.
  • Guggenheim Capital's biggest Q2 2024 reduction was Invesco QQQ Trust, cutting an estimated $19.6M.
  • Guggenheim Capital fully exited VanEck Gold Miners ETF in Q2 2024, selling an estimated $46.2M.
  • Guggenheim Capital's ten largest holdings make up 21% of its $14.1B portfolio in Q2 2024.
  • Guggenheim Capital opened 111 new positions and closed 123 in Q2 2024.
  • Guggenheim Capital's portfolio value fell 0.63% quarter-over-quarter to $14.1B.

Based on Guggenheim Capital's 13F filing for Q2 2024, filed 14 Aug 2024.